The current paradigm regarding sodium handling in animals and humans postulates that total 23 body sodium is regulated predominately via regulation of extracellular volume. Active sodium 24 storage independent of volume retention is thought to be negligible. However, studies in animals, 25 hypertensive patients and healthy humans suggest water-free storage of sodium in skin. We 26 hypothesized that tissue sodium concentrations ([Na] T ) found in humans vary and reflect 27 regulation due to variable glycosaminoglycan content due to variable expression of XYLT-1. 27 28 patients on dialysis and 21 living kidney transplant donors free of clinically detectable edema 29 were studied. During surgery, abdominal skin, muscle and arteries were biopsied.
[Na] T was 30 determined by inductively coupled plasma -optical emission spectrometry, semiquantitative 31 glycosaminoglycan content with Alcian stain, XYLT-1 expression by real-time PCR.
[Na] T of arteries 32
were ranging between 0.86 and 9.83 g/kg wet weight and were significantly higher in arteries 33 (4.52 + 1.82 g/kg) than in muscle (2.03 + 1.41 g/kg; p<0.001) or skin (3.24 + 2.26 g/kg wet weight; 34
Introduction 43
Implications of sodium handling for health and disease are vividly discussed and there is an ample 44 body of literature suggesting a contribution of increased sodium intake to the development of 45 hypertension and cardiovascular disease including aortic stiffness, smooth muscle hypertrophy and 46 fibrinoid media necrosis of arteries via a variety of mechanisms (1, 7, 10 ). In the current 47 pathophysiologic understanding, sodium is thought to be closely linked to body water, primarily the 48 extracellular compartment. While this model is well suited to explain many responses to sodium 49 loading, it only partially explains the extremes of the spectrum, i.e. compensation of sodium losses in 50 sodium-deplete populations or sodium handling in individuals subjected to sodium loading despite 51 impaired limited renal excretion capacity such as infants or anuric patients on dialysis. Interestingly, 52
experimental studies in rats exposed to deoxycorticosterone suggest the possibility of water-free 53 storage of sodium via incorporation into glycosaminoglycans (18). Recently, water-free sodium-54 storage has been proposed for hypertensive and even healthy humans (9, 14). These studies focused 55 on skin and muscles and demonstrated increased tissue sodium concentrations, scattered over a 56 wide range from approximately 40 to 110 mmol / kg wet weight (9). 57
We hypothesized that patients with advanced renal disease requiring dialysis exhibit a decreased 58 capacity to excrete sodium. When exposed to a western diet they might experience constant sodium 59 loading resulting in expanded sodium stores due to increased glycosaminoglycan synthesis. As one 60 prominent clinical manifestation of sodium loading is via arterial pathology, we also wondered if 61 variable and tissue specific sodium concentrations can be found in humans. 62
To test this hypothesis we measured tissue sodium concentrations ([Na] T ) of skin, muscle and 63 arteries in dialysis patients and healthy kidney donors. In order to further investigate possible 64 mechanisms of osmotically inactive sodium storage, we studied glycosaminoglycan content and 65 expression of XYLT-1, the enzyme initiating glycosaminoglycan synthesis. 66
Materials and Methods 68
Patients 69
Dialysis patients (n = 27), mostly recipients of living related kidney transplants, and healthy controls 70 (n = 21), i.e. living kidney donors at the time of organ donation, were included in this study. 71
Demographic data were extracted from the patients' medical records. Laboratory data were 72 obtained on the day prior to surgery except for iPTH and serum phosphate for which the most recent 73 value from the preceding six months was used. Serum osmolality was calculated from serum 74 concentrations of sodium, glucose and urea. Blood pressure was measured in clinic prior to hospital 75 admission. Kidney donors were also routinely examined by 24 hour ambulatory blood pressure 76
monitoring. 77 78

Tissue biopsies 79
Only patients free from clinically detectable edema were included. During surgery tissue samples 80 were obtained from the abdominal incision from skin, muscle and epigastric artery. Sodium 81 containing fluids for preparation or irrigation were strictly avoided. Immediately after excision of the 82 biopsy, a small aliquot (approximately 2 x 3 x 3 mm) was stored in RNAlater (Ambion, Darmstadt, 83
Germany) until further analysis. The larger portion of the biopsy specimen was divided. One part was 84 fixed and stored in 4% neutral buffered formalin for histopathological analysis, one part was frozen 85 at -20°C without further additives for measurement of tissue sodium concentration. 86
87
Measurement of tissue sodium concentrations 88
[Na] T was determined from frozen specimens by inductively coupled plasma-optical emission 89 spectroscopy. The samples (100 mg) were properly weighed into quartz vessels. Subsequently, 1 mL 90 HNO 3 , suprapure, subboiling distilled (Merck, Darmstadt) was added. The vessels were closed and 91 introduced into a pressure digestion system (Seif, Unterschleissheim, Germany) for 10 h at 170 0 C. 92
The resulting clear solution was filled up exactly to 5 mL with Milli-Q H 2 O and was then ready for 93 element determination. 94
An inductively coupled plasma atomic emission spectrometer (ICP-AES) "Optima 7300" system (Perkin 95
Elmer, Rodgau-Jügesheim, Germany) was used for sodium and potassium determination in samples. 96
Sample introduction was carried out using a peristaltic pump (flow rate 0.8 mL/min) connected to a 97
Seaspray nebulizer with a cyclon spray chamber. The measured spectral element line was: Na: 589.592 nm. 98
The RF power was set to 1350 W, the plasma gas was 15 L Ar /min, the auxiliary gas was 0.2 L Ar/min, 99 whereas the nebulizer gas was 600 mL Ar/min. Every ten measurements three blank determinations and a 100 control determination of a certified Na standard were performed. Calculation of results was carried out on 101 a computerized lab-data management system, relating the sample measurements to calibration curves, 102 blank determinations, control standards and the weight of the digested sample. 103
104
Estimation of glycosaminoglycan expression in biopsy samples 105
Glycosaminoglycan content was assessed in skin, muscle and arterial samples by standardized Alcian 106
Blue -PAS staining. In brief, the protocol followed consisted of deparaffinization in xylol and 107 hydration through alcohols, rinsing in distilled water, staining with Alcian Blue (pH 2.5) for 10 108 minutes, rinsing in distilled water, staining with 0.5% Periodic acid for 5 minutes, rinsing in distilled 109 water, optimized Schiff's solution for 5 minutes, rinsing in tap water for 5 minutes, staining with 110 haemalaun for 5 minutes, rinsing in running water for 5 minutes, rinsing in distilled water and 111 dehydrating through alcohol and xylol. 112
The intensity of Alcian Blue staining was scored semiquantitatively by a pathologist blinded to patient 113 identification and tissue sodium concentrations. 114
XYLT1 expression 116
In order to examine regulation of glycosaminoglycan synthesis, XYLT1-expression was analyzed in 117 aliquots of the respective biopsies by RT-PCR. RNA isolation was performed as described previously 118 (2). Of the total RNA, 1 μg was used for cDNA synthesis by Superscript I/II reverse transcriptase 119 (Invitrogen, Karlsruhe, Germany) with hexanucleotides as primers (Roche, Mannheim, Germany). RT-120 PCR products from 25 arteries and 31 muscle biopsies were obtained. qPCR was performed by an 121 ABIPrism7000 Sequence detection system (Applied Biosystems, Darmstadt, Germany) (20). and qPCR were performed as described above. XYLT1 expression was normalized to 18S RNA. 135
136
Statistical analysis 137
Descriptive statistics were used to summarize the baseline characteristics of donors and recipients 138 and were compared using univariate ANOVA. Data are reported as mean + standard deviation.
[Na] Tbetween various tissues were compared with a two-sided t-test. 
Demographic data 152
Descriptive demographic data are given for dialysis patients and healthy controls in Table 1 . Patients 153 and living kidney donors were well matched with respect to age, weight and BMI. As expected, 154 dialysis patients were more likely to be male and exhibited significantly higher systolic blood pressure 155 on both office and 24-hour measurements as well as higher pulse pressure. Dialysis patients also 156 received significantly more antihypertensive medications. 157 Serum-creatinine, urea, potassium, phosphate, calculated serum-osmolality and iPTH were 158 significantly higher in dialysis patients whereas hemoglobin was significantly lower. Serum 159 concentrations for sodium, glucose, CRP and bicarbonate were not different between the groups 160 (Table 1) . 161
Tissue specific sodium concentrations 163
Adequate samples for analysis were available from skin in 48 patients, muscle in 47 patients and 164 artery in 32 patients. 165
[Na] T exhibited substantial interindividual variability, ranging between 0.9 and 9.8 g/kg wet weight 166 for arteries, 0.6 and 7.1 g/kg wet weight for muscle and 1.0 and 14 g/kg wet weight for skin. There 167 was an 11-fold to 14-fold increase in [Na] T between lowest and highest measurements. Also, mean 168 In this human study we demonstrate significant amounts of sodium in various tissues which 213 substantially exceed the concentrations to be expected from sodium concentrations in extracellular 214 fluid and intracellular concentrations. Furthermore, measured [Na] T vary between tissues such as 215 muscle, skin and arteries with the highest amounts of sodium to be found in arterial tissue. We also 216 report a similar degree of variability in tissue sodium concentrations compared to studies in rats and 217 humans from other groups (9, 18). In contrast to this wide range of interindividual variation, [Na] T 218 were tightly correlated within one individual. As well as reported by Titze et al., this wide range of 219 variability observed in our study is far beyond the physiologic variability in extracellular volume (9). 220
Thus, water-free sodium storage appears as another possible explanation for this observation. 221
Indeed, the presence of such a slow-exchangeable sodium pool has been suspected from 222 equilibration studies using radioactive sodium half a century ago (16). As a potential site of sodium-223 storage previously incorporation into glycosaminoglycans has been suspected, based on 224 glycosaminoglycan measurements in the skin of Wistar rats with and without chronic sodium loading, 225 structural analysis of hyaluronan as well as binding studies in glycosaminoglycan rich tissues (6, 11, 226 21). Our study also reports a significant correlation of the intensity of glycosaminoglycan staining of 227 tissue biopsies and tissue sodium concentrations. While similar variability of glycosaminoglycan 228 expression in arteries and myocardium have been reported by others, our observations link this 229 observation to [Na] T . 230
Aside from water-free sodium storage osmotically neutral sodium potassium exchange also has to be 231 considered as an explanation for our observations. However, in our patients [K] T and [Na] T showed a 232 highly significant positive correlation in skin and artery. As glycosaminoglycans may incorporate bothcations, sodium and potassium, into their tertiary structure, this observation adds further to the 234 Our observations support the relevance of glycosaminoglycan expression. Glycosaminoglycans are 258 known to serve as scaffolds which bind lipoproteins, cytokines and glycosaminoglycan 259 overproduction has experimentally been linked to increased aortic calcification (8, 12, 13) . Hence a 260 number of potential sequelae of such increased glycosaminoglycan synthesis may be suspected in 261 the long-term follow-up of the patients included in our study. 262
In contrast to previous studies, we could not find any difference between patients with impaired 263 sodium excretion and healthy humans. This observation is supported by the work of Dahlmann et al. 264
in which there was no significant difference in non-invasively measured tissue sodium concentrations 265 in skin and muscle between dialysis patients and healthy controls (4). Possibly due to the rather 266 narrow age range of our patients and a preponderance of post-menopausal women, we were not 267 able to detect any effect of age or gender on sodium tissue concentrations (4). Instead, we detected 268 
